Antiarrhythmic therapy for atrial fibrillation: current guidelines of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery (ESC/EACTS)
Open Access
- 31 August 2021
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (5), 2962
- https://doi.org/10.15829/1728-8800-2021-2962
Abstract
Антиаритмическая терапия в лечении фибрилляции предсердий: современные рекомендации Европейского общества кардиологов и Европейской ассоциации кардио-торакальных хирургов (ESC/EACTS)This publication has 10 references indexed in Scilit:
- Early Rhythm-Control Therapy in Patients with Atrial FibrillationThe New England Journal of Medicine, 2020
- Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationEmergencias, 2019
- Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial FibrillationJAMA, 2019
- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart AssociationJournal of the American College of Cardiology, 2019
- Clinical effectiveness of a systematic “pill-in-the-pocket” approach for the management of paroxysmal atrial fibrillationHeart Rhythm, 2018
- Pharmacological conversion of recent-onset atrial fibrillation: A systematic reviewScandinavian Cardiovascular Journal, 2012
- Lenient versus Strict Rate Control in Patients with Atrial FibrillationThe New England Journal of Medicine, 2010
- A Comparative Study of the Efficacy and Safety of Procainamide Versus Propafenone Versus Amiodarone for the Conversion of Recent-Onset Atrial FibrillationThe American Journal of Cardiology, 2007
- Ablate and pace strategy for atrial fibrillation: long-term outcome of AIRCRAFT trialEP Europace, 2007
- Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillationJournal of Invasive Cardiology, 2001